(Q46448115)

English

A phase I trial of the oral, multikinase inhibitor sorafenib in combination with carboplatin and paclitaxel

scientific article

Statements

A phase I trial of the oral, multikinase inhibitor sorafenib in combination with carboplatin and paclitaxel (English)

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit